Literature DB >> 14700590

Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies.

Dominique Reumaux1, Patrick Duthilleul, Dirk Roos.   

Abstract

Little is known about the etiologies of diseases associated with circulating antineutrophil cytoplasm autoantibodies (ANCA), such as primary vasculitides and inflammatory bowel diseases. However, the understanding of immune mechanisms supposedly involved in the pathogenesis of these diseases is still growing. In the present review, we first focus on the mechanisms triggering the development of ANCA, including the potential role of microbial superantigens and the possible defect(s) in the progression of apoptosis or in the removal of apoptotic cells. We next concentrate on the contribution of ANCA to the clinical symptoms and on the pathogenic role of ANCA, including the accessibility of ANCA antigens as targets for circulating antibodies and the mode of action of ANCA. Mechanisms of neutrophil activation by ANCA include the engagement of Fcgamma receptors, the possible mechanisms of neutrophil-mediated tissue damage, and the neutrophil-endothelial interaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14700590     DOI: 10.1016/j.humimm.2003.09.013

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  18 in total

Review 1.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity.

Authors:  F Yu; M-H Zhao; Y-K Zhang; Y Zhang; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 4.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

5.  PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect?

Authors:  N Sule Yaşar Bilge; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2012-01-08       Impact factor: 2.631

6.  Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.

Authors:  B M Spriewald; O Witzke; R Wassmuth; R R Wenzel; M-L Arnold; T Philipp; J R Kalden
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 7.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

8.  Arterial distensibility in chronic inflammatory rheumatic disorders.

Authors:  Mustafa Yildiz
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

9.  Chimeric antibodies to proteinase 3 of IgG1 and IgG3 subclasses induce different magnitudes of functional responses in neutrophils.

Authors:  Rachel Colman; Abdullah Hussain; Margaret Goodall; Steven P Young; Tanya Pankhurst; Xiaomei Lu; Royston Jefferis; Caroline O S Savage; Julie M Williams
Journal:  Ann Rheum Dis       Date:  2007-01-04       Impact factor: 19.103

Review 10.  Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; William F C Rigby
Journal:  J Transl Autoimmun       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.